+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brachytherapy Treatment Planning System Market - Global Forecast 2026-2032- Product Image
Brachytherapy Treatment Planning System Market - Global Forecast 2026-2032- Product Image
New

Brachytherapy Treatment Planning System Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011099
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The brachytherapy treatment planning system market is evolving rapidly as clinical demands and operational realities converge, making advanced integration, workflow automation, and regulatory adaptability central to provider strategies. Leaders require validated, interoperable solutions to optimize care delivery and futureproof investment in precision oncology platforms.

Market Snapshot: Brachytherapy Treatment Planning System Market

The brachytherapy treatment planning system market expanded from USD 1.02 billion in 2025 to USD 1.13 billion in 2026, and is projected to achieve a CAGR of 12.89%, ultimately reaching USD 2.39 billion by 2032. This growth trajectory is driven by investments in digital health, advanced imaging integration, and rising demand for efficient, quality-driven cancer care workflows, positioning this segment as a core enabler within global oncology services.

Scope & Segmentation of the Brachytherapy Planning System Market

  • Technology Platforms: Incorporates modern practices such as multimodal imaging fusion, algorithm-based plan optimization, and cloud-enabled deployment for remote access and resilience.
  • Clinical Applications: Delivers high-precision planning for breast, gynecological, and prostate cancers, each with distinct requirements for anatomical segmentation and dose modeling.
  • Treatment Modalities: Supports high dose rate, low dose rate, and pulsed systems, leveraging specific source libraries and temporal modeling techniques for accuracy.
  • End User Types: Targets ambulatory surgical centers, hospitals, cancer treatment centers, and research institutes, each with unique interface, interoperability, and service demands.
  • Component Architectures: Offers choices between integrated software-hardware platforms and software-only/cloud-native models, including associated service bundles such as training and maintenance.
  • Geographic Regions: Covers the Americas, Europe, Middle East & Africa, and Asia-Pacific, adjusted for local regulatory environments, infrastructure maturity, and scale requirements.

Key Takeaways for Senior Decision-Makers

  • Modern brachytherapy planning platforms have evolved beyond purely computational tools to act as strategic enablers for clinical workflow orchestration and precision treatment delivery.
  • Integrated imaging, adaptive dose optimization, and robust verification processes underpin reproducible, quality-driven clinical practice and are critical for operational resilience.
  • Adoption criteria increasingly focus on modularity, cloud readiness, and enterprise interoperability, supporting phased procurement, rapid deployment, and secure scalability across networks of care.
  • Growing demand for image-guided, hypofractionated, and patient-centric therapies places pressure on platforms to deliver high anatomical fidelity, rapid turnaround, and continuous quality monitoring.
  • Vendor collaboration, including partnerships with imaging hardware suppliers and EMR integrators, is essential for delivering validated end-to-end solutions and meeting emerging regulatory and security standards.
  • Product selection depends on aligning technical capabilities with specific institutional needs—whether for turnkey deployments, research extensibility, or low-footprint implementations.

Influence of Tariff and Supply Chain Pressures

Recent tariff changes have prompted recalibration in procurement and deployment strategies. Increased costs on hardware and imaging components incentivize centers to assess lifecycle value and flexibility of acquisition models. Localization and phased upgrades, alongside bundled service contracts, help stabilize operations amid shifting trade policies. Stakeholders are intensifying supply chain diversification and contractual protections to ensure reliable technology implementation and financial risk management.

Methodology & Data Sources

This analysis synthesizes interviews with clinicians, physicists, procurement leaders, and vendors; reviews of regulatory filings, technical literature, and clinical studies; as well as conference proceedings and patent landscapes. Cross-validation of perspectives ensures data integrity, while updates from independent clinical advisors and regulatory disclosures strengthen the reliability of insights.

Why This Report Matters

  • Provides actionable intelligence for aligning procurement, integration, and clinical adoption of brachytherapy planning systems with institutional priorities and risk frameworks.
  • Enables decision-makers to benchmark technology strategies, anticipate regional adoption trends, and navigate procurement pressures that impact cost and operational continuity.
  • Supports product, commercial, and clinical leaders in identifying validated, interoperable platforms that safely scale advanced oncology therapies across diverse care settings.

Conclusion

Brachytherapy planning systems now serve as foundational platforms in precision oncology, linking technical advances to measurable gains in clinical and operational performance. Forward-looking strategies centered on validation, interoperability, and adaptable service models will be vital to sustaining excellence in cancer care delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Brachytherapy Treatment Planning System Market, by Component
8.1. Integrated Systems
8.1.1. Image Guidance Modules
8.1.2. Planning Modules
8.2. Services
8.2.1. Maintenance
8.2.2. Training & Support
8.3. Software Only
8.3.1. Cloud Based
8.3.2. Standalone Software
9. Brachytherapy Treatment Planning System Market, by Treatment Type
9.1. High Dose Rate
9.2. Low Dose Rate
9.3. Pulsed Dose Rate
10. Brachytherapy Treatment Planning System Market, by Application
10.1. Breast
10.2. Gynecological
10.3. Prostate
11. Brachytherapy Treatment Planning System Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Cancer Treatment Centers
11.3. Hospitals
11.4. Research Institutes
12. Brachytherapy Treatment Planning System Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Brachytherapy Treatment Planning System Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Brachytherapy Treatment Planning System Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Brachytherapy Treatment Planning System Market
16. China Brachytherapy Treatment Planning System Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Bebig Medical GmbH
17.6. Becton, Dickinson and Company
17.7. Best Medical International, Inc.
17.8. Best Nomos, LLC
17.9. CIVCO Radiotherapy
17.10. Cook Medical, Inc.
17.11. CR Bard, Inc.
17.12. Eckert & Ziegler Strahlen- und Medizintechnik AG
17.13. Elekta AB
17.14. Huiheng Medical, Inc.
17.15. IsoAid LLC
17.16. Isoray Medical, Inc.
17.17. Mevion Medical Systems, Inc.
17.18. MIM Software Inc.
17.19. Nucletron B.V.
17.20. Oncura, Inc.
17.21. Panacea Medical Technologies Pvt. Ltd.
17.22. Sun Nuclear Corporation
17.23. Theragenics Corp.
17.24. Theragenics Corporation
17.25. Varian Medical Systems International AG
17.26. Varian Medical Systems, Inc.
17.27. Varian Proton Therapy, Inc.
17.28. Xoft, Inc.
List of Figures
FIGURE 1. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY IMAGE GUIDANCE MODULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY IMAGE GUIDANCE MODULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY IMAGE GUIDANCE MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PLANNING MODULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PLANNING MODULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PLANNING MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TRAINING & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TRAINING & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TRAINING & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY STANDALONE SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY STANDALONE SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY STANDALONE SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PULSED DOSE RATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PULSED DOSE RATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PULSED DOSE RATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY BREAST, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY BREAST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY GYNECOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY GYNECOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY GYNECOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PROSTATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY CANCER TREATMENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY CANCER TREATMENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. EUROPE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 101. EUROPE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 102. EUROPE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 103. EUROPE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 104. EUROPE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 105. EUROPE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 117. AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 118. AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 119. AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 120. AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 121. AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. ASEAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 134. ASEAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 135. ASEAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 136. ASEAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 137. ASEAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 138. ASEAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. ASEAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. GCC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GCC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 142. GCC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 143. GCC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 144. GCC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 145. GCC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 146. GCC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. GCC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. BRICS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. BRICS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 158. BRICS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 159. BRICS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 160. BRICS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 161. BRICS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 162. BRICS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. BRICS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. G7 BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. G7 BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 166. G7 BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 167. G7 BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 168. G7 BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 169. G7 BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 170. G7 BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. G7 BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. NATO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. NATO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 174. NATO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 175. NATO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 176. NATO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 177. NATO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 178. NATO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. NATO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 190. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 191. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 192. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 193. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY SOFTWARE ONLY, 2018-2032 (USD MILLION)
TABLE 194. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 195. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Brachytherapy Treatment Planning System market report include:
  • Bebig Medical GmbH
  • Becton, Dickinson and Company
  • Best Medical International, Inc.
  • Best Nomos, LLC
  • CIVCO Radiotherapy
  • Cook Medical, Inc.
  • CR Bard, Inc.
  • Eckert & Ziegler Strahlen- und Medizintechnik AG
  • Elekta AB
  • Huiheng Medical, Inc.
  • IsoAid LLC
  • Isoray Medical, Inc.
  • Mevion Medical Systems, Inc.
  • MIM Software Inc.
  • Nucletron B.V.
  • Oncura, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Sun Nuclear Corporation
  • Theragenics Corp.
  • Theragenics Corporation
  • Varian Medical Systems International AG
  • Varian Medical Systems, Inc.
  • Varian Proton Therapy, Inc.
  • Xoft, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.13 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.39 Billion
Compound Annual Growth Rate12.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Brachytherapy Devices Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Brachytherapy Devices Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 87 Pages
  • Global
From
Brachytherapy Applicator Market - Global Forecast 2025-2030 - Product Image

Brachytherapy Applicator Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Brachytherapy Treatment Planning Systems - Global Strategic Business Report - Product Image

Brachytherapy Treatment Planning Systems - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Brachytherapy Devices Market - Product Image

Brachytherapy Devices Market

  • Report
  • 150 Pages
  • Global
From
Brachytherapy Devices Market - Global Forecast 2026-2032 - Product Image

Brachytherapy Devices Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From

About the Market

Brachytherapy Treatment Planning Systems (BTPS) are computer-aided systems used to plan and deliver radiation therapy treatments. BTPS are used in Nuclear Medicine and Radiopharmacology to accurately target radiation to a specific area of the body. The systems are designed to provide precise radiation doses to the target area while minimizing radiation exposure to surrounding healthy tissue. BTPS typically include a 3D imaging system, a treatment planning system, and a delivery system. The 3D imaging system is used to create a 3D model of the patient's anatomy, which is then used to plan the radiation treatment. The treatment planning system is used to calculate the radiation dose and to determine the optimal placement of the radiation sources. The delivery system is used to deliver the radiation to the target area. Some companies in the BTPS market include Elekta, Varian Medical Systems, Philips Healthcare, and Accuray. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.